Bandingkan Harga & Kinerja Kusuma Kemindo Sentosa Tbk. (KKES) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Kusuma Kemindo Sentosa Tbk. dan Organon Pharma Indonesia Tbk.: Kusuma Kemindo Sentosa Tbk. diperdagangkan di Rp89 (kapitalisasi pasar 136,5 M, volume 24 jam 20,67 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Kusuma Kemindo Sentosa Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| KKES | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 136,5 M | 104,4 M |
Volume | 20,67 jt | — |
Lot | 206,71 rb | — |
Perputaran | 1,8 M | — |
Harga Rata-rata | 87,3 | — |
Nilai Transaksi | 1,8 M | — |
Harga Ekuilibrium Indikatif | 89 | — |
Volume Ekuilibrium Indikatif | 3,04 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Kusuma Kemindo Sentosa Tbk.
PT Kusuma Kemindo Sentosa Tbk (the Company) was established based on Notarial Deed No. 78 dated November 9, 1990 and amended by Deed No. 64 dated September 16, 1991, both were madebefore Notary James Herman Rahardjo, S.H., Notary in Jakarta.
Selengkapnya di halaman KKES →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
